{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:55:59Z","timestamp":1790398559417,"version":"4.1.0"},"reference-count":37,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/jcpt.12061","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T12:23:01Z","timestamp":1364991781000},"page":"301-308","source":"Crossref","is-referenced-by-count":52,"title":["Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis"],"prefix":"10.1155","volume":"38","author":[{"given":"X.","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pence","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Inciardi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Bhutada","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences; California Northstate University College of Pharmacy; Rancho Cordova CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"10.1111\/jcpt.12061-BIB0001|jcpt12061-cit-0001","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ctrv.2009.11.001","article-title":"An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome","volume":"36","author":"Mughal","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/jcpt.12061-BIB0002|jcpt12061-cit-0002","first-page":"369","article-title":"How we treat tumor lysis syndrome","volume":"4","author":"Muslimani","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"10.1111\/jcpt.12061-BIB0003|jcpt12061-cit-0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3324\/haematol.12327","article-title":"Tumor lysis syndrome: current perspective","volume":"93","author":"Hochberg","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jcpt.12061-BIB0004|jcpt12061-cit-0004","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ncponc0581","article-title":"The management of tumor lysis syndrome","volume":"3","author":"Rampello","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1111\/jcpt.12061-BIB0005|jcpt12061-cit-0005","first-page":"50","article-title":"Tumor lysis syndrome","volume":"1","author":"Rajendran","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1111\/jcpt.12061-BIB0006|jcpt12061-cit-0006","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1503\/cmaj.111251","article-title":"Spontaneous tumour lysis syndrome","volume":"8","author":"Kekre","year":"2012","journal-title":"CMAJ"},{"key":"10.1111\/jcpt.12061-BIB0007|jcpt12061-cit-0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/jcpt.12061-BIB0008|jcpt12061-cit-0008","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1345\/aph.1C336","article-title":"Rasburicase for the treatment and prevention of hyperuricemia","volume":"37","author":"Yim","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12061-BIB0009|jcpt12061-cit-0009","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0010|jcpt12061-cit-0010","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1200\/JCO.2003.04.115","article-title":"Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study","volume":"21","author":"Coiffier","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0011|jcpt12061-cit-0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.leu.2403566","article-title":"Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial","volume":"19","author":"Jeha","year":"2005","journal-title":"Leukemia"},{"key":"10.1111\/jcpt.12061-BIB0012|jcpt12061-cit-0012","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1200\/JCO.2009.26.8896","article-title":"Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone-Results of a multicenter phase III study","volume":"20","author":"Cortes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0013|jcpt12061-cit-0013","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1200\/JCO.2010.32.6751","article-title":"Rasburicase and tumor lysis syndrome: lower dosage, consideration of indications, and hyperhydration","volume":"29","author":"Darmon","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0014|jcpt12061-cit-0014","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2010.32.7650","article-title":"Reply to M. Darmon et al.","volume":"29","author":"Cortes","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0015|jcpt12061-cit-0015","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1345\/aph.1E002","article-title":"Use of single-dose rasburicase in an obese female","volume":"38","author":"Arnold","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12061-BIB0016|jcpt12061-cit-0016","first-page":"130","article-title":"Single dose of rasburicase for treatment of hyperuricemia in acute kidney injury: a report of 3 cases","volume":"5","author":"Hooman","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"10.1111\/jcpt.12061-BIB0017|jcpt12061-cit-0017","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1345\/aph.1P296","article-title":"Fixed-dose rasburicase 6\u00a0mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients","volume":"44","author":"Vines","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12061-BIB0018|jcpt12061-cit-0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1592\/phco.26.6.806","article-title":"Single-dose rasburicase 6\u00a0mg in the management of tumor lysis syndrome in adults","volume":"26","author":"McDonnell","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12061-BIB0019|jcpt12061-cit-0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0609.2010.01457.x","article-title":"Single fixed dose of rasburicase (6\u00a0mg maximum) for treatment of tumor lysis syndrome in adults","volume":"85","author":"Giraldez","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1111\/jcpt.12061-BIB0020|jcpt12061-cit-0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0609.2005.00550.x","article-title":"Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase","volume":"75","author":"Hummel","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1111\/jcpt.12061-BIB0021|jcpt12061-cit-0021","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/14656560902781972","article-title":"A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function","volume":"10","author":"Malaguarnera","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/jcpt.12061-BIB0022|jcpt12061-cit-0022","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/sj.leu.2403161","article-title":"Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome","volume":"17","author":"Hummel","year":"2003","journal-title":"Leukemia"},{"key":"10.1111\/jcpt.12061-BIB0023|jcpt12061-cit-0023","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/bmt.2010.212","article-title":"Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies","volume":"46","author":"Trifilio","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12061-BIB0024|jcpt12061-cit-0024","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.leukres.2004.09.004","article-title":"A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy","volume":"29","author":"Liu","year":"2005","journal-title":"Leuk Res"},{"key":"10.1111\/jcpt.12061-BIB0025|jcpt12061-cit-0025","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/annonc\/mdr490","article-title":"A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome","volume":"23","author":"Vadhan-Raj","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1111\/jcpt.12061-BIB0026|jcpt12061-cit-0026","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1592\/phco.28.6.685","article-title":"Evaluation of a Single Fixed Dose of Rasburicase 7.5\u00a0mg for the Treatment of Hyperuricemia in Adults with Cancer","volume":"28","author":"Reeves","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12061-BIB0027|jcpt12061-cit-0027","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1078155210364180","article-title":"Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome","volume":"17","author":"Knoebel","year":"2011","journal-title":"J Oncol Pharm Pract"},{"key":"10.1111\/jcpt.12061-BIB0028|jcpt12061-cit-0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2008.00994.x","article-title":"Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach","volume":"34","author":"Campara","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12061-BIB0029|jcpt12061-cit-0029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1743-7563.2011.01464.x","article-title":"Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature review","volume":"7","author":"Chiang","year":"2011","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0030|jcpt12061-cit-0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1743-7563.2008.00145.x","article-title":"Single dose rasburicase in tumor lysis: One hospital's experience","volume":"4","author":"Steel","year":"2008","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0031|jcpt12061-cit-0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.11575","article-title":"Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model","volume":"93","author":"Montesinos","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jcpt.12061-BIB0032|jcpt12061-cit-0032","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jcpt.12061-BIB0033|jcpt12061-cit-0033","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12061-BIB0034|jcpt12061-cit-0034","first-page":"2916","article-title":"Serum uric acid unrelated to cancer incidence in humans","volume":"48","author":"Hiatt","year":"1988","journal-title":"Cancer Res"},{"key":"10.1111\/jcpt.12061-BIB0035|jcpt12061-cit-0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1705379","article-title":"Reduced -dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia","volume":"37","author":"Trifilio","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12061-BIB0036|jcpt12061-cit-0036","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08998280.2005.11928082","article-title":"Rasburicase (Elitek): a novel agent for tumor lysis syndrome","volume":"18","author":"Ueng","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1111\/jcpt.12061-BIB0037|jcpt12061-cit-0037","first-page":"129","article-title":"Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)","volume":"2","author":"Pession","year":"2008","journal-title":"Biologics"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12061","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12061","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12061\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T08:01:29Z","timestamp":1715155289000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12061","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}